Medpace is a global late-stage contract research organization, or CRO, that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. The company was founded over 30 years ago in Cincinnati. It is principally based in the US but also operates in Europe, Asia, South America, Africa, and Australia.
Medpace's small and midsize biopharma customers are very dependent on outsourced clinical trials since they do not have the capacity to run trials in-house.
Significant pullbacks in biotech funding or declines in outsourcing penetration rates have a material impact on Medpace's growth.
|
Metric
|
MEDP
|
IQV
|
FTRE
|
|---|---|---|---|
Price/Earnings (Normalized) | 35.04 | 20.91 | 145.12 |
Price/Book Value | 38.46 | 6.95 | 3.52 |
Price/Sales | 6.19 | 2.61 | 0.67 |
Price/Cash Flow | 27.25 | 16.94 | 34.53 |
|
Metric
|
MEDP
|
IQV
|
FTRE
|
|---|---|---|---|
Quick Ratio | 0.66 | 0.62 | 0.85 |
Current Ratio | 0.73 | 0.71 | 0.96 |
Interest Coverage | — | 2.99 | 0.08 |
|
Metric
|
MEDP
|
IQV
|
FTRE
|
|---|---|---|---|
Return on Assets (Normalized) | 26.82% | 7.22% | 2.15% |
Return on Equity (Normalized) | 130.01% | 34.41% | 10.56% |
Return on Invested Capital (Normalized) | 97.04% | 12.37% | 7.32% |
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc
TMO
| LOCK|qn#TN!G< | LOCK|%FR | $241B | |||
| Danaher Corp
DHR
| LOCK|HJ@$JXk% | LOCK|#q | $149B | |||
| Agilent Technologies Inc
A
| LOCK|jMxVs>B | LOCK|ZZZ | $47B | |||
| IQVIA Holdings Inc
IQV
| LOCK|PmCx$%$ | LOCK|P?@Cn | $43B | |||
| Waters Corp
WAT
| LOCK|Q^PXHzx | LOCK|dx | $42B | |||
| IDEXX Laboratories Inc
IDXX
| LOCK|Fn%^>WL# | LOCK|Qj | $41B | |||
| Illumina Inc
ILMN
| LOCK|dsGl$Wk | LOCK|Bpy! | $40B | |||
| Mettler-Toledo International Inc
MTD
| LOCK|$#hTsF<r | LOCK|>?@@> | $30B | |||
| Quest Diagnostics Inc
DGX
| LOCK|P<<N!$ | LOCK|Bsp&n | $26B | |||
| Labcorp Holdings Inc
LH
| LOCK|@#j>&w<% | LOCK|@@$X | $25B |
United States